Endobronchial Ultrasound Biopsy Market Size Forecast From 2026 To 2030: Key Industry Trends
Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
Endobronchial Ultrasound Biopsy Market Forecast: Value Set To Climb From $0.71 Billion To $0.93 Billion
The endobronchial ultrasound biopsy market has shown robust growth over recent years. Projections indicate it will expand from $0.66 billion in 2025 to $0.71 billion in 2026, at a compound annual growth rate (CAGR) of 6.7%. The historical increase in this market can be attributed to several factors, including the rising prevalence of lung cancer cases, the increasing adoption of minimally invasive diagnostic procedures, the growth in hospital-based bronchoscopy units, advancements in ultrasound-guided biopsy technologies, and expanding awareness of early thoracic disease diagnosis.
The market size for endobronchial ultrasound biopsy is projected to demonstrate robust expansion in the coming years. It is anticipated to reach $0.93 billion by 2030, growing at a compound annual growth rate (CAGR) of 7.0%. This growth over the forecast period can be attributed to several factors, including an escalating demand for precision-guided pulmonary diagnostics, the increasing adoption of single-use biopsy devices, the expansion of AI-enabled bronchoscopy imaging systems, rising investments in cancer diagnostic infrastructure, and the greater utilization of outpatient and ambulatory biopsy procedures. Significant trends expected during this period involve the increasing uptake of minimally invasive mediastinal biopsy procedures, a growing preference for single-use endobronchial ultrasound devices, an increasing demand for accuracy in real-time lymph node sampling, the expansion of lung cancer screening and diagnostic programs, and the enhanced use of advanced ultrasound-guided peripheral lung lesion localization.
Get A Free Sample Report With In-Depth Market Insights:
Endobronchial Ultrasound Biopsy Market Growth Factors Behind Sustained Expansion
The expanding occurrence of lung cancer is anticipated to fuel the progression of the endobronchial ultrasound biopsy market in the coming years. Lung cancer, a form of aggressive tumor, is defined by unchecked cellular proliferation in lung tissues, capable of invading adjacent areas or spreading to distant organs. The increase in lung cancer cases stems from elements like greater smoking rates and environmental exposures that heighten the likelihood of lung malignancy. Endobronchial ultrasound biopsy facilitates accurate, minimally invasive collection of samples from lung and mediastinal tissues, thus enabling precise diagnosis, staging, and ongoing monitoring of lung cancer. This process subsequently informs specific treatment choices and enhances patient prognoses. For example, in March 2026, data from the Cancer Research UK (CRUK), an organization based in the UK, indicates that for women in the UK, the European age-standardised (AS) incidence rate of lung cancer is projected to grow by 2% between 2024–2026 and 2038–2040, climbing from around 75.8 to 77.6 cases per 100,000 women per year. Consequently, the rising frequency of lung cancer is propelling the expansion of the endobronchial ultrasound biopsy market.
Endobronchial Ultrasound Biopsy Market Segment Outlook: Which Categories Are Growing Fastest?
The endobronchial ultrasound biopsy market covered in this report is segmented –
1) By Procedure Type: Convex Probe Endobronchial Ultrasound Guided Biopsy, Radial Probe Endobronchial Ultrasound Guided Biopsy
2) By Product Type: Endobronchial Ultrasound Scopes, Biopsy Needles And Sampling Consumables, Ultrasound Processors And Imaging Systems, Accessories And Ancillary Devices
3) By Usability: Reusable Devices, Single Use Devices
4) By Application: Lung Cancer Diagnosis And Staging, Granulomatous And Infectious Disease Evaluation, Other Applications
5) By End User: Hospitals And Specialty Cancer Centers, Ambulatory Surgical Centers, Diagnostic Imaging And Biopsy Centers
Subsegments:
1) By Convex Probe Endobronchial Ultrasound Guided Biopsy: Transbronchial Needle Aspiration Guided Procedures, Real Time Lymph Node Sampling Procedures, Mediastinal Staging Biopsy Procedures, Central Lung Lesion Biopsy Procedures, Combined Bronchoscopic Ultrasound Guided Sampling Procedures
2) By Radial Probe Endobronchial Ultrasound Guided Biopsy: Peripheral Lung Lesion Localization Procedures, Guide Sheath Assisted Biopsy Procedures, Transbronchial Forceps Biopsy Procedures, Brush Cytology Sampling Procedures, Fluoroscopy Assisted Peripheral Biopsy Procedures
Endobronchial Ultrasound Biopsy Market Industry Trends Fueling Future Revenue Growth
Leading companies operating within the endobronchial ultrasound biopsy market are concentrating on developing innovative products, specifically next-generation EBUS bronchoscopes, to boost diagnostic precision and refine minimally invasive lung cancer interventions. These advanced EBUS bronchoscopes are sophisticated endoscopic instruments equipped with integrated high-resolution ultrasound probes, facilitating real-time visualization of airways and lymph nodes, which enables medical professionals to conduct more accurate, minimally invasive lung biopsies compared to conventional bronchoscopes. For instance, in September 2025, Olympus Corporation, a Japan-based medical technology firm, introduced the BF-UC190F EBUS bronchoscope, an inventive tool designed to enhance diagnostic exactness and operational effectiveness in thoracic oncology. The BF-UC190F incorporates a slenderer, more pliable insertion tube, a high-resolution ultrasound probe, and superior maneuverability, allowing clinicians to reach challenging lymph nodes while minimizing patient discomfort. Its ergonomic structure and improved imaging functionalities contribute to safer, quicker biopsies and diminish the requirement for repeat procedures. This sophisticated bronchoscope is especially advantageous in the early detection and staging of lung cancer, providing real-time direction for needle aspiration and tissue sampling.
Endobronchial Ultrasound Biopsy Market Leading Players And Competitive Positioning
Major companies operating in the endobronchial ultrasound biopsy market are Medtronic plc, Siemens Healthcare Private Limited, FUJIFILM Holdings Corporation, Koninklijke Philips N. V., GE HealthCare Technologies Inc., Boston Scientific Corporation, Konica Minolta Inc., Intuitive Surgical Inc., Olympus Corporation, Shenzhen Mindray Bio-Medical Electronics Co. Ltd., STERIS plc, Teleflex Incorporated, Canon Medical Systems Corporation, Cook Group Incorporated, CONMED Corporation, PENTAX Medical, Esaote S. p. A., Medi-Globe Technologies GmbH, ENDO-FLEX GmbH, Taewoong Medical Co. Ltd., ACE Medical Devices Private Limited, Body Vision Medical Ltd., Clinodevice S. r. l.
View The Full Endobronchial Ultrasound Biopsy Market Report:
Endobronchial Ultrasound Biopsy Market Regional Distribution: Which Areas Power Market Growth?
North America was the largest region in the endobronchial ultrasound biopsy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the endobronchial ultrasound biopsy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
